Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × Interleukin-2 × Clear all

Sponsor

Conditions

Melanoma 38 Neoplasm Metastasis 16 Leukemia, Myeloid, Acute 13 Skin Neoplasms 10 Kidney Neoplasms 10 Leukemia 9 Carcinoma, Renal Cell 9 Neoplasms 7 Ovarian Neoplasms 6 Breast Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Congenital Abnormalities 4 Neuroblastoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Papillomavirus Infections 2 Lymphoma, Mantle-Cell 2 Hodgkin Disease 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1

Interventions

Everolimus 16 Octreotide 6 pembrolizumab 5 lanreotide 5 Sunitinib 5 Magnetic Resonance Spectroscopy 5 gallium Ga 68 dotatate 4 cabozantinib 4 Nivolumab 4 Carboplatin 4 telotristat ethyl 3 lenvatinib 3 arginyllysine 3 Specimen Handling 3 Etoposide 3 Erlotinib Hydrochloride 3 Bevacizumab 3 surufatinib 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 amino-acid, glucose, and electrolyte solution 2 X-Rays 2 Temozolomide 2 Sorafenib 2 Phantoms, Imaging 2 Paclitaxel 2 Oxaliplatin 2 Ipilimumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡